The POPPY Cohort is supported by various sources, including:
- investigator-initated grants from several industry sources (Gilead Sciences, ViiV Healthcare, Bristol-Myers Squibb, Janssen-Cilag and Merck Sharp and Dohme);
- funding from the UK National Institute of Health Research (NIHR) through a Senior Investigator Award to Professor Sabin (grant no. NF-SI-0514-10075);
- funding from the Biomedical Research Council (BRC) at Imperial College London to Professor Winston;
- via Clinical Research Network (CRN) support at National Health Service sites in England;
None of the sponsors (industry or otherwise) has any influence on the study design, the interpretation of study findings or the decision to present study findings.
In addition, several POPPY sub-studies have been funded through grants awarded by the British HIV Association (BHIVA), University College London and GlaxoSmithKline to study investigators.